ANG Lifesciences

{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "34.30",
    "chg": -1.4,
    "chgp": "-3.92%",
    "dir": -1,
    "prev_price": "35.70",
    "mcapval": "47.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE236W01016",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "00:59 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "900 ",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4115147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ANGLifesciences_mojoScore_4115147.png",
        "date": "2026-07-22 10:10:32",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4096418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ANGLifesciences_mojoScore_4096418.png",
        "date": "2026-07-10 10:10:04",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4077000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_mojoScore_4077000.png",
        "date": "2026-06-29 10:10:05",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 49.69",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-hits-new-52-week-high-at-rs4969-4072801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_priceRelatedfactors_4072801.png",
        "date": "2026-06-25 09:56:17",
        "description": "Surging past its previous peaks, ANG Lifesciences India Ltd reached a fresh 52-week high of Rs 49.69 on 25 Jun 2026, marking a remarkable rally of 73.68% over the past year against the Sensex’s decline of 6.33%. This milestone caps a three-day winning streak that has delivered a 62.24% return, fuelled by a confluence of strong technical signals and sustained price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 41.41",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-hits-new-52-week-high-at-rs4141-4070516",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_priceRelatedfactors_4070516.png",
        "date": "2026-06-24 12:11:01",
        "description": "With a surge to Rs 41.41 on 24 Jun 2026, ANG Lifesciences India Ltd has reached a fresh 52-week high, marking a 46.74% gain over the past year and significantly outperforming the Sensex, which declined 6.28% in the same period. This milestone reflects a powerful alignment of technical indicators and sustained price momentum."
      },
      {
        "title": "Golden Cross Forms in ANG Lifesciences India Ltd — On a Day the Stock Fell 2.55%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-forms-golden-cross-indicating-potential-bullish-breakout-4061855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_goldencross_4061855.png",
        "date": "2026-06-18 18:00:52",
        "description": "The 50-day moving average has crossed above the 200-day moving average for ANG Lifesciences India Ltd, signalling a golden cross on 18 Jun 2026. Yet, the stock declined 2.55% on the same day, while monthly technical indicators remain only mildly bullish or neutral. This divergence between the moving averages and price action calls for a closer examination of the signal’s reliability."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4061140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_mojoScore_4061140.png",
        "date": "2026-06-18 10:10:04",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "ANG Lifesciences Gains 6.88%: Quarterly Turnaround and Market Challenges Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-gains-688-quarterly-turnaround-and-market-challenges-shape-the-week-4051979",
        "imagepath": "",
        "date": "2026-06-13 16:12:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Strong quarterly turnaround reported with 39.7% revenue growth</p>\n                    <p><strong>2 June:</strong> Stock continued upward momentum, gaining 2.74%</p>\n                    <p><strong>3 June:</strong> Minor pullback of 0.31% amid mixed market sentiment</p>\n                    <p><strong>4 June:</strong> Decline of 2.61% as market showed resilience</p>\n                    <p><strong>5 June:</strong> Sharp rebound with 4.25% gain, closing the week at Rs.29.19</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.27.31</div></div>\n  ..."
      },
      {
        "title": "Are ANG Lifesciences India Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-ang-lifesciences-india-ltd-latest-results-good-or-bad-4028109",
        "imagepath": "",
        "date": "2026-06-01 19:28:36",
        "description": "ANG Lifesciences India Ltd's latest financial results for Q1 FY27 present a mixed picture of operational performance and ongoing challenges. The company reported net sales of ₹23.50 crores, reflecting a year-on-year growth of 39.71% and a sequential increase of 25.47%. This growth suggests a recovery in demand conditions after a period of revenue volatility. However, despite this revenue growth, the company continues to face significant profitability issues, as evidenced by a net loss of ₹1.38 crores, which, while 70.95% lower than the previous quarter's loss, still indicates persistent financial struggles.\n\nThe operating margin, excluding other income, improved to 11.36%, marking the highest level in eight quarters. This improvement is attributed to better cost management, particularly a reduction in employee costs. Nevertheless, the path from operating profit to net profit remains fraught with challenges,..."
      }
    ],
    "total": 309,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "21-Jul-2026",
      "details": "Reg 74(5) Certificate",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "19-Jun-2026",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Jun-2026",
      "details": "Newspaper Publication of Audited Financial Results for the quarter and year ended March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ANG Lifesciences India Ltd is Rated Sell

2026-07-22 10:10:32

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with the latest insights into the company's performance and outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-07-10 10:10:04

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-06-29 10:10:05

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 49.69

2026-06-25 09:56:17

Surging past its previous peaks, ANG Lifesciences India Ltd reached a fresh 52-week high of Rs 49.69 on 25 Jun 2026, marking a remarkable rally of 73.68% over the past year against the Sensex’s decline of 6.33%. This milestone caps a three-day winning streak that has delivered a 62.24% return, fuelled by a confluence of strong technical signals and sustained price momentum.

Read full news article

Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 41.41

2026-06-24 12:11:01

With a surge to Rs 41.41 on 24 Jun 2026, ANG Lifesciences India Ltd has reached a fresh 52-week high, marking a 46.74% gain over the past year and significantly outperforming the Sensex, which declined 6.28% in the same period. This milestone reflects a powerful alignment of technical indicators and sustained price momentum.

Read full news article

Golden Cross Forms in ANG Lifesciences India Ltd — On a Day the Stock Fell 2.55%. What the Mixed Signals Mean

2026-06-18 18:00:52

The 50-day moving average has crossed above the 200-day moving average for ANG Lifesciences India Ltd, signalling a golden cross on 18 Jun 2026. Yet, the stock declined 2.55% on the same day, while monthly technical indicators remain only mildly bullish or neutral. This divergence between the moving averages and price action calls for a closer examination of the signal’s reliability.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-06-18 10:10:04

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

ANG Lifesciences Gains 6.88%: Quarterly Turnaround and Market Challenges Shape the Week

2026-06-13 16:12:39

Key Events This Week

1 June: Strong quarterly turnaround reported with 39.7% revenue growth

2 June: Stock continued upward momentum, gaining 2.74%

3 June: Minor pullback of 0.31% amid mixed market sentiment

4 June: Decline of 2.61% as market showed resilience

5 June: Sharp rebound with 4.25% gain, closing the week at Rs.29.19

Week Open

Rs.27.31

...

Read full news article

Are ANG Lifesciences India Ltd latest results good or bad?

2026-06-01 19:28:36

ANG Lifesciences India Ltd's latest financial results for Q1 FY27 present a mixed picture of operational performance and ongoing challenges. The company reported net sales of ₹23.50 crores, reflecting a year-on-year growth of 39.71% and a sequential increase of 25.47%. This growth suggests a recovery in demand conditions after a period of revenue volatility. However, despite this revenue growth, the company continues to face significant profitability issues, as evidenced by a net loss of ₹1.38 crores, which, while 70.95% lower than the previous quarter's loss, still indicates persistent financial struggles. The operating margin, excluding other income, improved to 11.36%, marking the highest level in eight quarters. This improvement is attributed to better cost management, particularly a reduction in employee costs. Nevertheless, the path from operating profit to net profit remains fraught with challenges,...

Read full news article

View All News